Taufon® 4%, 15 ml

Trade name
Taufon®
International non-proprietary name
Taurine
Composition
1 l contains
drug substance: Taurine 40.0g;
additive agent: water for injections.
Proposed clinical use
dystrophic lesions of the retina
hereditary retinal abiotrophy of eyes
corneal degeneration and injury
senile, diabetic, traumatic and radiation cataracts
open-angle glaucoma (for lowering intraocular pressure in complex with eye drops containing β-blockers)